These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Delaware | 16-1387013 |
|
(State or other jurisdiction
of incorporation or organization)
|
(I.R.S. Employer Identification No.) |
|
Page
|
||
|
PART I FINANCIAL INFORMATION
|
||
| 6 | ||
|
PART II OTHER INFORMATION
|
||
|
ULTRALIFE CORPORATION
|
||||||||
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
||||||||
|
(Dollars in Thousands, Except Per Share Amounts)
|
||||||||
|
ASSETS
|
(Unaudited)
September 30,
|
December 31,
2011
|
||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 4,959 | $ | 5,320 | ||||
|
Restricted cash
|
412 | 166 | ||||||
|
Trade accounts receivable (less allowance for doubtful accounts
of $331 at September 30, 2012 and $683 at December 31, 2011)
|
20,254 | 19,903 | ||||||
|
Inventories
|
33,092 | 34,967 | ||||||
|
Due from insurance company
|
721 | 1,730 | ||||||
|
Deferred tax asset - current
|
155 | 161 | ||||||
|
Income taxes receivable
|
117 | 220 | ||||||
|
Prepaid expenses and other current assets
|
1,645 | 1,766 | ||||||
|
Total current assets
|
61,355 | 64,233 | ||||||
|
Property, plant and equipment, net
|
12,375 | 12,588 | ||||||
|
Other assets:
|
||||||||
|
Goodwill
|
16,337 | 18,356 | ||||||
|
Intangible assets, net
|
5,164 | 5,533 | ||||||
|
Security deposits and other long-term assets
|
98 | 105 | ||||||
| 21,599 | 23,994 | |||||||
|
Total Assets
|
$ | 95,329 | $ | 100,815 | ||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Current portion of debt
|
$ | - | $ | - | ||||
|
Accounts payable
|
11,930 | 13,766 | ||||||
|
Income taxes payable
|
2 | 11 | ||||||
|
Deferred tax liability - current
|
73 | 187 | ||||||
|
Other current liabilities
|
7,654 | 9,194 | ||||||
|
Total current liabilities
|
19,659 | 23,158 | ||||||
|
Long-term liabilities:
|
||||||||
|
Deferred tax liability - long-term
|
4,156 | 4,170 | ||||||
|
Other long-term liabilities
|
275 | 261 | ||||||
|
Total long-term liabilities
|
4,431 | 4,431 | ||||||
|
Commitments and contingencies (Note 10)
|
||||||||
|
Shareholders' equity:
|
||||||||
|
Ultralife equity:
|
||||||||
|
Preferred stock, par value $0.10 per share, authorized 1,000,000 shares;
none issued and outstanding
|
- | - | ||||||
|
Common stock, par value $0.10 per share, authorized 40,000,000 shares;
issued - 18,802,976 at September 30, 2012 and 18,716,921 at December 31, 2011
|
1,883 | 1,874 | ||||||
|
Capital in excess of par value
|
173,416 | 172,309 | ||||||
|
Accumulated other comprehensive loss
|
(1,066 | ) | (985 | ) | ||||
|
Accumulated deficit
|
(95,271 | ) | (92,280 | ) | ||||
|
|
78,962 | 80,918 | ||||||
|
Less --Treasury stock, at cost -- 1,372,757 shares at September 30, 2012 and
1,372,757 shares at December 31, 2011 outstanding
|
7,658 | 7,658 | ||||||
|
Total Ultralife equity
|
71,304 | 73,260 | ||||||
|
Noncontrolling interest
|
(65 | ) | (34 | ) | ||||
|
Total shareholders' equity
|
71,239 | 73,226 | ||||||
|
Total Liabilities and Shareholders' Equity
|
$ | 95,329 | $ | 100,815 | ||||
|
ULTRALIFE CORPORATION
|
||||||||||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
|
||||||||||||||||
|
(In Thousands, Except Per Share Amounts)
|
||||||||||||||||
|
(unaudited)
|
||||||||||||||||
|
Three-Month Periods Ended
|
Nine-Month Periods Ended
|
|||||||||||||||
|
September 30
|
October 2,
|
September 30
|
October 2,
|
|||||||||||||
|
2012
|
2011
|
2012
|
2011
|
|||||||||||||
|
Revenues
|
$ | 26,181 | $ | 35,204 | $ | 72,388 | $ | 106,231 | ||||||||
|
Cost of products sold
|
17,962 | 25,844 | 53,109 | 80,897 | ||||||||||||
|
Gross profit
|
8,219 | 9,360 | 19,279 | 25,334 | ||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development (including $65, $77, $195 and $234,
respectively, of amortization of intangible assets)
|
1,596 | 2,294 | 5,706 | 6,913 | ||||||||||||
|
Selling, general, and administrative (including $57, $78, $177 and $235
respectively, of amortization of intangible assets)
|
4,869 | 5,521 | 16,041 | 17,775 | ||||||||||||
|
Total operating expenses
|
6,465 | 7,815 | 21,747 | 24,688 | ||||||||||||
|
|
||||||||||||||||
|
Operating income (loss)
|
1,754 | 1,545 | (2,468 | ) | 646 | |||||||||||
|
Other income (expense):
|
||||||||||||||||
|
Interest income
|
1 | 2 | 4 | 4 | ||||||||||||
|
Interest expense
|
(97 | ) | (126 | ) | (316 | ) | (444 | ) | ||||||||
|
Miscellaneous
|
(15 | ) | 49 | 17 | 339 | |||||||||||
|
Income (loss) from continuing operations before income taxes
|
1,643 | 1,470 | (2,763 | ) | 545 | |||||||||||
|
|
||||||||||||||||
|
Income tax provision-current
|
120 | 67 | 387 | 134 | ||||||||||||
|
Income tax provision - deferred
|
55 | 55 | 50 | 164 | ||||||||||||
|
Total income taxes provision
|
175 | 122 | 437 | 298 | ||||||||||||
|
Net income (loss) from continuing operations
|
1,468 | 1,348 | (3,200 | ) | 247 | |||||||||||
|
Discontinued operations:
|
||||||||||||||||
|
Income (loss) from discontinued operations, net of tax
|
200 | 4 | 178 | (4,174 | ) | |||||||||||
|
Net income (loss)
|
1,668 | 1,352 | (3,022 | ) | (3,927 | ) | ||||||||||
|
Net loss attributable to noncontrolling interest
|
11 | 11 | 31 | 39 | ||||||||||||
|
Net income (loss) attributable to Ultralife
|
$ | 1,679 | $ | 1,363 | $ | (2,991 | ) | $ | (3,888 | ) | ||||||
|
Other comprehensive income (loss):
|
||||||||||||||||
|
Foreign currency translation adjustments
|
(204 | ) | (19 | ) | (81 | ) | 268 | |||||||||
|
Comprehensive income (loss) attributable to Ultralife
|
$ | 1,475 | $ | 1,344 | $ | (3,072 | ) | $ | (3,620 | ) | ||||||
|
Net income (loss) attributable to Ultralife common shareholders - basic
|
||||||||||||||||
|
Continuing operations
|
$ | 0.09 | $ | 0.08 | $ | (0.18 | ) | $ | 0.02 | |||||||
|
Discontinued operations
|
$ | 0.01 | $ | 0.00 | $ | 0.01 | $ | (0.24 | ) | |||||||
|
Total
|
$ | 0.10 | $ | 0.08 | $ | (0.17 | ) | $ | (0.22 | ) | ||||||
|
Net income (loss) attributable to Ultralife common shareholders - diluted
|
||||||||||||||||
|
Continuing operations
|
$ | 0.09 | $ | 0.08 | $ | (0.18 | ) | $ | 0.02 | |||||||
|
Discontinued operations
|
$ | 0.01 | $ | 0.00 | $ | 0.01 | $ | (0.24 | ) | |||||||
|
Total
|
$ | 0.10 | $ | 0.08 | $ | (0.17 | ) | $ | (0.22 | ) | ||||||
|
Weighted average shares outstanding - basic
|
17,418 | 17,313 | 17,390 | 17,295 | ||||||||||||
|
Weighted average shares outstanding - diluted
|
17,418 | 17,341 | 17,390 | 17,295 | ||||||||||||
|
ULTRALIFE CORPORATION
|
||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
||||||||
|
(Dollars in Thousands)
|
||||||||
|
(unaudited)
|
||||||||
|
Nine-Month Periods Ended
|
||||||||
|
September 30
|
October 2,
|
|||||||
|
2012
|
2011
|
|||||||
|
OPERATING ACTIVITIES
|
||||||||
|
Net (loss)
|
$ | (3,022 | ) | $ | (3,927 | ) | ||
|
(Income) loss from discontinued operations, net of tax
|
(178 | ) | 4,174 | |||||
|
Adjustments to reconcile net (loss) from continuing operations
to net cash provided from operating activities:
|
||||||||
|
Depreciation and amortization of financing fees
|
2,566 | 2,720 | ||||||
|
Amortization of intangible assets
|
372 | 469 | ||||||
|
Loss on long-lived asset disposal and write-offs
|
13 | 105 | ||||||
|
Foreign exchange gain
|
(3 | ) | (326 | ) | ||||
|
Impairment of goodwill and long-lived assets
|
- | - | ||||||
|
Non-cash stock-based compensation
|
1,001 | 882 | ||||||
|
Changes in deferred income taxes
|
74 | 199 | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
3,265 | 8,090 | ||||||
|
Inventories
|
1,766 | 1,397 | ||||||
|
Income taxes receivable
|
104 | - | ||||||
|
Prepaid expenses and other current assets
|
(39 | ) | 92 | |||||
|
Insurance receivable relating to fires
|
1,014 | (1,724 | ) | |||||
|
Income taxes payable
|
(9 | ) | (24 | ) | ||||
|
Accounts payable and other liabilities
|
(5,020 | ) | (5,395 | ) | ||||
|
Net cash provided from (used in) operating activities from continuing operations
|
1,904 | 6,732 | ||||||
|
Net cash provided from operating activities from discontinued operations
|
(2,133 | ) | 86 | |||||
|
Net cash provided from (used in) operating activities
|
(229 | ) | 6,818 | |||||
|
INVESTING ACTIVITIES
|
||||||||
|
Purchase of property and equipment
|
(2,011 | ) | (1,878 | ) | ||||
|
Proceeds from asset disposal
|
- | 7 | ||||||
|
Change in restricted cash
|
(250 | ) | 468 | |||||
|
Payments for acquired companies, net of cash acquired
|
- | (50 | ) | |||||
|
Net cash used in investing activities from continuing operations
|
(2,261 | ) | (1,453 | ) | ||||
|
Net cash provided from investing activities from discontinued operations
|
2,133 | 102 | ||||||
|
Net cash used in investing activities
|
(128 | ) | (1,351 | ) | ||||
|
FINANCING ACTIVITIES
|
||||||||
|
Net change in revolving credit facility
|
- | (6,060 | ) | |||||
|
Proceeds from issuance of common stock
|
115 | 57 | ||||||
|
Principal payments on debt and capital lease obligations
|
- | (6 | ) | |||||
|
Net cash provided from (used in) financing activities from continuing operations
|
115 | (6,009 | ) | |||||
|
Net cash used in financing activities from discontinued operations
|
- | (128 | ) | |||||
|
Net cash provided from (used in) financing activities
|
115 | (6,137 | ) | |||||
|
Effect of exchange rate changes on cash
|
(119 | ) | 522 | |||||
|
Change in cash and cash equivalents
|
(361 | ) | (148 | ) | ||||
|
Cash and cash equivalents at beginning of period
|
5,320 | 4,641 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 4,959 | $ | 4,493 | ||||
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
||||||||
|
Cash paid for income taxes
|
$ | 291 | $ | 158 | ||||
|
Cash paid for interest
|
$ | 184 | $ | 353 | ||||
|
Three-Month Periods Ended
|
Nine-Month Periods Ended
|
|||||||||||||||
|
September 30,
2012
|
October 2,
2011
|
September 30,
2012
|
October 2,
2011
|
|||||||||||||
|
Net sales
|
$ | 1,267 | $ | 802 | $ | 3,404 | $ | 1,786 | ||||||||
|
Income (Loss) from discontinued operations
|
(59 | ) | 16 | (3 | ) | (415 | ) | |||||||||
|
Provision (Benefit) for income taxes
|
(196 | ) | 12 | (174 | ) | 36 | ||||||||||
|
Income (Loss) from discontinued operations,
net of tax
|
137 | 4 | 171 | (451 | ) | |||||||||||
|
Three-Month Periods Ended
|
Nine-Month Periods Ended
|
|||||||||||||||
|
September 30,
2012
|
October 2,
2011
|
September 30,
2012
|
October 2,
2011
|
|||||||||||||
|
Net sales
|
$ | - | $ | - | $ | - | $ | 3,895 | ||||||||
|
Gain/(loss) from discontinued operations
|
63 | - | 8 | (3,796 | ) | |||||||||||
|
Provision for income taxes
|
- | - | - | - | ||||||||||||
|
Gain/(loss) from discontinued operations,
net of tax
|
63 | - | 8 | (3,796 | ) | |||||||||||
|
Three-Month Periods Ended
|
Nine-Month Periods Ended
|
|||||||||||||||
|
September 30,
2012
|
October 2,
2011
|
September 30,
2012
|
October 2,
2011
|
|||||||||||||
|
Inventory and fixed asset write-downs
|
$ | - | $ | - | $ | - | $ | 941 | ||||||||
|
Employee related, including
termination benefits
|
- | - | - | 703 | ||||||||||||
|
Lease termination costs
|
- | - | - | 250 | ||||||||||||
|
Other costs
|
- | - | - | 1,030 | ||||||||||||
|
Total Exit Costs
|
$ | - | $ | - | $ | - | $ | 2,924 | ||||||||
|
Cash Component
|
$ | - | $ | - | $ | - | $ | 1,984 | ||||||||
|
September 30, 2012
|
December 31, 2011
|
|||||||
|
Raw materials
|
$ | 15,977 | $ | 20,097 | ||||
|
Work in process
|
5,095 | 4,770 | ||||||
|
Finished goods
|
12,020 | 10,100 | ||||||
| $ | 33,092 | $ | 34,967 | |||||
|
September 30, 2012
|
December 31, 2011
|
|||||||
|
Land
|
$ | 123 | $ | 123 | ||||
|
Buildings and leasehold improvements
|
7,274 | 7,000 | ||||||
|
Machinery and equipment
|
46,044 | 44,770 | ||||||
|
Furniture and fixtures
|
1,904 | 1,894 | ||||||
|
Computer hardware and software
|
4,180 | 3,815 | ||||||
|
Construction in progress
|
889 | 641 | ||||||
| 60,414 | 58,243 | |||||||
|
Less: Accumulated depreciation
|
48,039 | 45,655 | ||||||
| $ | 12,375 | $ | 12,588 | |||||
|
Battery &
Energy Products
|
Communications
Systems
|
Discontinued
Operations
|
Total
|
|||||||||||||
|
Balance at December 31, 2010
|
$ | 4,758 | $ | 11,493 | $ | 2,025 | $ | 18,276 | ||||||||
|
Effect of foreign currency
translations
|
73 | - | - | 73 | ||||||||||||
|
Balance at October 2, 2011
|
4,831 | 11,493 | 2,025 | 18,349 | ||||||||||||
|
Effect of foreign currency
translations
|
7 | - | - | 7 | ||||||||||||
|
Balance at December 31, 2011
|
4,838 | 11,493 | 2,025 | 18,356 | ||||||||||||
|
Sale of RedBlack
Communications
|
(2,025 | ) | (2,025 | ) | ||||||||||||
|
Effect of foreign currency
translations
|
6 | - | - | 6 | ||||||||||||
|
Balance at September 30, 2012
|
$ | 4,844 | $ | 11,493 | $ | - | $ | 16,337 | ||||||||
|
September 30, 2012
|
||||||||||||
|
Gross
Assets
|
Accumulated
Amortization
|
Net
|
||||||||||
|
Trademarks
|
$ | 3,564 | $ | - | $ | 3,564 | ||||||
|
Patents and technology
|
4,493 | 3,635 | 858 | |||||||||
|
Customer relationships
|
3,995 | 3,308 | 687 | |||||||||
|
Distributor relationships
|
379 | 324 | 55 | |||||||||
|
Non-compete agreements
|
216 | 216 | - | |||||||||
|
Total intangible assets
|
$ | 12,647 | $ | 7,483 | $ | 5,164 | ||||||
|
December 31, 2011
|
||||||||||||
|
Gross
Assets
|
Accumulated
Amortization
|
Net
|
||||||||||
|
Trademarks
|
$ | 3,563 | $ | - | $ | 3,563 | ||||||
|
Patents and technology
|
4,492 | 3,440 | 1,052 | |||||||||
|
Customer relationships
|
3,993 | 3,143 | 850 | |||||||||
|
Distributor relationships
|
378 | 310 | 68 | |||||||||
|
Non-compete agreements
|
396 | 396 | - | |||||||||
|
Total intangible assets
|
$ | 12,822 | $ | 7,289 | $ | 5,533 | ||||||
|
Excess Availability
|
LIBOR Rate Plus
|
|||
|
Greater than $10,000
|
3.00 | % | ||
|
Greater than $6,000 but less than or equal to $10,000
|
3.25 | % | ||
|
Greater than $3,000 but less than or equal to $6,000
|
3.50 | % | ||
|
Nine-Month Periods Ended
|
||||||||
|
September 30,
2012
|
October 2,
2011
|
|||||||
|
Risk-free interest rate
|
0.56 | % | 1.22 | % | ||||
|
Volatility factor
|
63.53 | % | 60.63 | % | ||||
|
Dividends
|
0.00 | % | 0.00 | % | ||||
|
Weighted average expected life (years)
|
3.91 | 3.82 | ||||||
|
Nine-Month
October 2, 2011
Period Ended
|
||||
|
Risk-free interest rate
|
2.74 | % | ||
|
Volatility factor
|
63.79 | % | ||
|
Dividends
|
0.00 | % | ||
|
Weighted average expected life (years)
|
5.51 | |||
|
Number
of Shares
|
Weighted
Average
Exercise Price
Per Share
|
Weighted
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
||||||||||
|
Shares under option at January 1, 2012
|
2,356,228 | $ | 8.34 | ||||||||||
|
Options granted
|
303,150 | 3.63 | |||||||||||
|
Options exercised
|
(28,000 | ) | 4.09 | ||||||||||
|
Options forfeited
|
(75,389 | ) | 4.82 | ||||||||||
|
Options expired
|
(213,267 | ) | 10.90 | ||||||||||
|
Shares under option at September 30, 2012
|
2,342,722 | $ | 7.66 |
4.83 years
|
$ | - | |||||||
|
Vested and expected to vest as of
September 30, 2012
|
2,232,729 | $ | 7.80 |
4.79 years
|
$ | - | |||||||
|
Options exercisable at September 30, 2012
|
848,930 | $ | 9.01 |
2.63 years
|
$ | - | |||||||
|
Number
of Shares
|
Weighted
Average
Grant Date
Fair Value
|
|||||||
|
Unvested at December 31, 2011
|
1,218 | $ | 11.33 | |||||
|
Granted
|
- | - | ||||||
|
Vested
|
(1,218 | ) | 11.33 | |||||
|
Forfeited
|
- | - | ||||||
|
Unvested at September 30, 2012
|
- | $ | - | |||||
|
Three-Month Periods Ended
|
Nine-Month Periods Ended
|
|||||||||||||||
|
September 30,
2012
|
October 2,
2011
|
September 30,
2012
|
October 2,
2011
|
|||||||||||||
|
|
||||||||||||||||
|
Income (Loss) from continuing operations
before Incomes Taxes (a)
|
$ | 1,643 | $ | 1,470 | $ | (2,763 | ) | $ | 545 | |||||||
|
Total Income Tax Provision (b)
|
$ | 175 | $ | 122 | $ | 437 | $ | 298 | ||||||||
|
Effective Tax Rate (b/a)
|
10.7 | % | 8.3 | % | 15.8 | % | 54.7 | % | ||||||||
|
Nine-Month Periods Ended
|
||||||||
|
September 30,
2012
|
October 2,
2011
|
|||||||
|
Balance at beginning of the period
|
$ | 6,779 | $ | - | ||||
|
|
||||||||
|
Increases related to current year tax
positions
|
- | - | ||||||
|
Increases related to prior year tax positions
|
- | - | ||||||
|
Decreases related to prior year tax positions
|
- | - | ||||||
|
Expiration of statute of limitations for
assessment of taxes
|
- | - | ||||||
|
Settlements
|
- | - | ||||||
|
Balance at end of the period
|
$ | 6,779 | $ | - | ||||
|
Three-Month Period Ended
|
Nine-Month Period Ended
|
|||||||||||||||
|
September 30,
2012
|
October 2,
2011
|
September 30,
2012
|
October 2,
2011
|
|||||||||||||
|
|
||||||||||||||||
|
Net Income (Loss) from continuing
operations attributable to Ultralife
|
$ | 1,479 | $ | 1,359 | $ | (3,169 | ) | $ | 286 | |||||||
|
Net Income (Loss) from continuing
operations attributable to participating securities (unvested restricted stock awards) (-0-, 1,000, -0- and -0- shares, respectively)
|
- | - | - | - | ||||||||||||
|
Net Income (Loss) from continuing
operations attributable to Ultralife common shareholders (a)
|
1,479 | 1,359 | (3,169 | ) | 286 | |||||||||||
|
Effect of Dilutive Securities
|
- | - | - | - | ||||||||||||
|
Net Income (Loss) from continuing
operations attributable to Ultralife common shareholders - Adjusted (b)
|
$ | 1,479 | $ | 1,359 | $ | (3,169 | ) | $ | 286 | |||||||
|
Net Income (Loss) from discontinued
operations attributable to Ultralife common shareholders (c)
|
$ | 200 | $ | 4 | $ | 178 | $ | (4,174 | ) | |||||||
|
Effect of Dilutive Securities
|
- | - | - | - | ||||||||||||
|
Net Income (Loss) from discontinued
operations attributable to Ultralife common shareholders - Adjusted (d)
|
$ | 200 | $ | 4 | $ | 178 | $ | (4,174 | ) | |||||||
|
Average Common Shares Outstanding –
Basic (e)
|
17,418,000 | 17,313,000 | 17,390,000 | 17,295,000 | ||||||||||||
|
Effect of Dilutive Securities:
|
||||||||||||||||
|
Stock Options / Warrants
|
- | 28,000 | - | - | ||||||||||||
|
Average Common Shares Outstanding –
Diluted (f)
|
17,418,000 | 17,341,000 | 17,390,000 | 17,295,000 | ||||||||||||
|
EPS – Basic (a/e) - continuing operations
|
$ | 0.09 | $ | 0.08 | $ | (0.18 | ) | $ | 0.02 | |||||||
|
EPS – Basic (c/e) - discontinued operations
|
$ | 0.01 | $ | 0.00 | $ | 0.01 | $ | (0.24 | ) | |||||||
|
EPS – Diluted (b/f) - continuing operations
|
$ | 0.09 | $ | 0.08 | $ | (0.18 | ) | $ | 0.02 | |||||||
|
EPS – Diluted (d/f) - discontinued operations
|
$ | 0.01 | $ | 0.00 | $ | 0.01 | $ | (0.24 | ) |
|
Balance at December 31, 2011
|
$ | 839 | ||
|
Accruals for warranties issued
|
394 | |||
|
Settlements made
|
(320 | ) | ||
|
Balance at September 30, 2012
|
$ | 913 |
|
Three-Month Period Ended September 30, 2012
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 16,633 | $ | 9,548 | $ | - | $ | - | $ | 26,181 | ||||||||||
|
Segment contribution
|
4,770 | 3,449 | - | (6,465 | ) | 1,754 | ||||||||||||||
|
Interest expense, net
|
(96 | ) | (96 | ) | ||||||||||||||||
|
Miscellaneous
|
(15 | ) | (15 | ) | ||||||||||||||||
|
Income taxes-current
|
(120 | ) | (120 | ) | ||||||||||||||||
|
Income taxes-deferred
|
(55 | ) | (55 | ) | ||||||||||||||||
|
Income from discontinued operations
|
200 | 200 | ||||||||||||||||||
|
Noncontrolling interest
|
11 | 11 | ||||||||||||||||||
|
Net income attributable to Ultralife
|
$ | 1,679 | ||||||||||||||||||
|
Total assets
|
$ | 54,031 | $ | 32,290 | $ | 11 | $ | 8,997 | $ | 95,329 | ||||||||||
|
Three-Month Period Ended October 2, 2011
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 28,834 | $ |
6,370
|
$ | - | $ | - | $ | 35,204 | ||||||||||
|
Segment contribution
|
7,929 | 1,431 | - | (7,815 | ) | 1,545 | ||||||||||||||
|
Interest expense, net
|
( 124 | ) | (124 | ) | ||||||||||||||||
|
Miscellaneous
|
49 | 49 | ||||||||||||||||||
|
Income taxes-current
|
(67 | ) | (67 | ) | ||||||||||||||||
|
Income taxes-deferred
|
(55 | ) | (55 | ) | ||||||||||||||||
|
Income from discontinued operations
|
4 | 4 | ||||||||||||||||||
|
Noncontrolling interest
|
11 | 11 | ||||||||||||||||||
|
Net income attributable to Ultralife
|
$ | 1,363 | ||||||||||||||||||
|
Total assets
|
$ | 54,661 | $ | 34,001 | $ | 2,885 | $ | 9,800 | $ | 101,347 | ||||||||||
|
Nine-Month Period Ended September 30, 2012
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 52,238 | $ | 20,150 | $ | - | $ | - | $ | 72,388 | ||||||||||
|
Segment contribution
|
12,476 | 6,803 | - | (21,747 | ) | (2,468 | ) | |||||||||||||
|
Interest expense, net
|
(312 | ) | (312 | ) | ||||||||||||||||
|
Miscellaneous
|
17 | 17 | ||||||||||||||||||
|
Income taxes-current
|
(387 | ) | (387 | ) | ||||||||||||||||
|
Income taxes-deferred
|
(50 | ) | (50 | ) | ||||||||||||||||
|
Income from discontinued operations
|
178 | 178 | ||||||||||||||||||
|
Noncontrolling interest
|
31 | 31 | ||||||||||||||||||
|
Net loss attributable to Ultralife
|
$ | (2,991 | ) | |||||||||||||||||
|
Total assets
|
$ | 54,031 | $ | 32,290 | $ | 11 | $ | 8,997 | $ | 95,329 | ||||||||||
|
Nine-Month Period Ended October 2, 2011
|
||||||||||||||||||||
|
Battery &
Energy
Products
|
Communications
Systems
|
Discontinued
Operations
|
Corporate
|
Total
|
||||||||||||||||
|
Revenues
|
$ | 84,321 | $ | 21,910 | $ | - | $ | - | $ | 106,231 | ||||||||||
|
Segment contribution
|
18,223 | 7,111 | - | (24,688 | ) | 646 | ||||||||||||||
|
Interest expense, net
|
(440 | ) | (440 | ) | ||||||||||||||||
|
Miscellaneous
|
339 | 339 | ||||||||||||||||||
|
Income taxes-current
|
(134 | ) | (134 | ) | ||||||||||||||||
|
Income taxes-deferred
|
(164 | ) | (164 | ) | ||||||||||||||||
|
Loss from discontinued operations
|
(4,174 | ) | (4,174 | ) | ||||||||||||||||
|
Noncontrolling interest
|
39 | 39 | ||||||||||||||||||
|
Net loss attributable to Ultralife
|
$ | (3,888 | ) | |||||||||||||||||
|
Total assets
|
$ | 54,661 | $ | 34,001 | $ | 2,885 | $ | 9,800 | $ | 101,347 | ||||||||||
|
Three-Month Periods Ended
|
||||||||
|
September 30,
2012
|
October 2,
2011
|
|||||||
|
Income (Loss) before Incomes Taxes (a)
|
$ | 1,643 | $ | 1,470 | ||||
|
Total Income Tax Provision (b)
|
$ | 175 | $ | 122 | ||||
|
Effective Tax Rate (b/a)
|
10.7 | % | 8.3 | % | ||||
|
Nine-Month Periods Ended
|
||||||||
|
September 30,
2012
|
October 2,
2011
|
|||||||
|
Income (Loss) before Incomes Taxes (a)
|
$ | (2,763 | ) | $ | 545 | |||
|
Total Income Tax Provision (b)
|
$ | 437 | $ | 298 | ||||
|
Effective Tax Rate (b/a)
|
15.8 | % | 54.7 | % | ||||
|
·
|
Adjusted EBITDA from continuing operations does not reflect (1) our cash expenditures or future requirements for capital expenditures or contractual commitments; (2) changes in, or cash requirements for, our working capital needs; (3) the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; (4) income taxes or the cash requirements for any tax payments; and (5) all of the costs associated with operating our business;
|
|
·
|
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in the future, and Adjusted EBITDA from continuing operations does not reflect any cash requirements for such replacements;
|
|
·
|
while stock-based compensation is a component of cost of products sold and operating expenses, the impact on our consolidated financial statements compared to other companies can vary significantly due to such factors as assumed life of the stock-based awards and assumed volatility of our common stock;
|
|
·
|
although discontinued operations does not reflect our current business operations, discontinued operations includes the costs we incurred by exiting our Energy Services business and divesting our RedBlack Communications business; and
|
|
·
|
other companies may calculate Adjusted EBITDA from continuing operations differently than we do, limiting its usefulness as a comparative measure.
|
|
Three-Month Periods Ended
|
Nine-Month Periods Ended
|
|||||||||||||||
|
September 30,
2012
|
October 2,
2011
|
September 30,
2012
|
October 2,
2011
|
|||||||||||||
|
Net income (loss) attributable to Ultralife
|
$ | 1,679 | $ | 1,363 | $ | (2,991 | ) | $ | (3,888 | ) | ||||||
|
Add: interest expense, net
|
96 | 124 | 312 | 440 | ||||||||||||
|
Add: income tax provision
|
175 | 122 | 437 | 298 | ||||||||||||
|
Add: depreciation and amortization of
financing fees
|
849 | 890 | 2,566 | 2,720 | ||||||||||||
|
Add: amortization of intangible assets
|
122 | 155 | 372 | 469 | ||||||||||||
|
Add: stock-based compensation expense
|
331 | 350 | 1,001 | 882 | ||||||||||||
|
Add (less): loss (gain) from
discontinued operations
|
(200 | ) | (4 | ) | (178 | ) | 4,174 | |||||||||
|
Adjusted EBITDA
|
$ | 3,052 | $ | 3,000 | $ | 1,519 | $ | 5,095 | ||||||||
|
Excess Availability
|
LIBOR Rate Plus
|
|||
|
Greater than $10,000
|
3.00 | % | ||
|
Greater than $6,000 but less than or equal to $10,000
|
3.25 | % | ||
|
Greater than $3,000 but less than or equal to $6,000
|
3.50 | % | ||
|
Exhibit
Index
|
Description of Document
|
Incorporated By Reference from:
|
|
|
2.1
|
Stock Purchase Agreement by and between BCF Solutions, Inc. and Ultralife Corporation.
|
Filed herewith
|
|
|
10.37
|
Second Amendment to Credit Facility, dated as of September 28, 2012, by and among Ultralife Corporation, RedBlack Communications, Inc., Ultralife Energy Services Corporation, and RBS Asset Finance, Inc.
|
Filed herewith
|
|
|
31.1
|
Rule 13a-14(a) / 15d-14(a) CEO Certifications
|
Filed herewith
|
|
|
31.2
|
Rule 13a-14(a) / 15d-14(a) CFO Certifications
|
Filed herewith
|
|
|
32
|
Section 1350 Certifications
|
Filed herewith
|
|
|
*101.INS
|
XBRL Instance Document
|
||
|
*101.SCH
|
XBRL Taxonomy Extension Schema Document
|
||
|
*101.CAL
|
XBRL Taxonomy Calculation Linkbase Document
|
||
|
*101.LAB
|
XBRL Taxonomy Label Linkbase Document
|
||
|
*101.PRE
|
XBRL Taxonomy Presentation Linkbase Document
|
||
|
*101.DEF
|
XBRL Taxonomy Definition Document
|
|
|
*
|
Pursuant to Rule 406T of Regulation S-T, the information in this exhibit is deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is otherwise not subject to liability under these sections.
|
|
|
2.1
|
Stock Purchase Agreement by and between BCF Solutions, Inc. and Ultralife Corporation.
|
|
|
10.37
|
Second Amendment to Credit Facility, dated as of September 28, 2012, by and among Ultralife Corporation, RedBlack Communications, Inc., Ultralife Energy Services Corporation, and RBS Asset Finance, Inc.
|
|
|
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
32
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Calculation Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Definition Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|